HRT and GLP-1 Together: Safety, Weight Loss and Results

Last updated November 13, 2026 · Reviewed by the Gala Health team

What menopause does to your weight

Midlife weight gain is mostly an aging story, but menopause changes where the weight goes and what it is made of. The Menopause Society puts average midlife weight gain at about 1.5 pounds a year, with a shift toward more fat, less lean mass and a slower basal metabolic rate, and fat moving toward the abdomen after menopause.

The SWAN study, which followed 1,246 women through the transition with body scans, found the change is in composition more than the scale. Once the menopause transition began, the rate of fat gain nearly doubled (from about 0.25 to 0.45 kg a year) and lean mass started to fall, until about two years after the final period. Total weight kept climbing at the same steady pace it had before.

Hormone therapy helps less than many women hope. The Menopause Society concludes that it may attenuate abdominal fat gain, but the effect is small, and calls it not a direct weight-loss treatment. GLP-1 medications are what actually move the number. That is why the two are paired: HRT for hot flashes, sleep and mood, a GLP-1 for menopause weight gain.

Is it safe to take HRT with a GLP-1? What the labels say

None of the semaglutide or tirzepatide labels mentions menopausal hormone therapy, estradiol or progesterone. What they do say is about how GLP-1 drugs slow stomach emptying, which can change how other pills are absorbed:

	Tirzepatide (Zepbound, Mounjaro)	Semaglutide (Wegovy, Ozempic)
Menopausal hormone therapy	Not mentioned	Not mentioned
Birth control pills	Switch to a non-oral method, or add a barrier method, for 4 weeks after starting and 4 weeks after each dose increase; non-oral hormonal contraceptives should not be affected	No contraception warning; in the label's study, ethinyl estradiol and levonorgestrel levels did not change meaningfully
Other pills	Use caution with oral medicines; monitor drugs that need a threshold level or have a narrow margin, such as warfarin	May affect absorption of oral medicines; monitor those with a narrow margin or that need monitoring

From the current FDA prescribing information for each drug (see Sources).

The birth control warning is the one people mix up with HRT. In Lilly's study, a single 5 mg dose of tirzepatide lowered the peak level of ethinyl estradiol in a combined pill by 59% and total exposure by 20%, and the label says this may make oral contraceptives less effective at preventing pregnancy. Menopausal HRT uses a different estrogen, estradiol rather than the synthetic ethinyl estradiol in birth control pills, for a different purpose, and the label does not extend the warning to it.

Three practical points follow:

If you are in perimenopause and still rely on the pill for contraception, the tirzepatide warning applies to you. Ask about a non-oral method.
An estradiol patch or gel or vaginal estradiol is absorbed through the skin or vaginal tissue, not the stomach, so slower gastric emptying is not a factor for those forms.
Oral progesterone, which protects the uterine lining, has not been studied with tirzepatide. A 2026 review in Maturitas calls an effect on it biologically plausible but unproven. Report any new or unexpected bleeding to your provider.

Both drug classes have their own warnings. Semaglutide and tirzepatide carry a boxed warning for thyroid C-cell tumors and are not used with a personal or family history of medullary thyroid carcinoma or MEN 2; see GLP-1 side effects. For estrogen, see is HRT safe.

Does HRT improve GLP-1 weight loss?

A handful of Mayo Clinic studies have compared postmenopausal women on a GLP-1 with and without hormone therapy. All of them looked back at medical records rather than randomizing women, so they show an association, not cause and effect.

Study	Women	Weight lost with HRT	Without HRT
Semaglutide, Menopause journal, 2024	106	16% at 12 months	12%
Semaglutide, Menopause Society meeting, 2026	2,379	11.9% at last follow-up (gap from 9 months on)	10.9%
Tirzepatide, Lancet Obstetrics, Gynaecology & Women's Health, 2026	120	17% at about 18 months; 45% lost at least 20%	14%; 18% lost at least 20%
Tirzepatide, Menopause Society meeting, 2026	1,476	6.6% at 3 months, then no significant difference	5.9% at 3 months

Retrospective cohort studies; the 2026 meeting results are conference abstracts. See Sources.

The semaglutide signal held up in the larger cohort; the tirzepatide one faded. The investigators offer a reason for caution: women already on HRT may differ in sleep, symptoms or habits. As the lead author put it in The Menopause Society's release, weight loss is not an indication for menopause hormone therapy, and the Spanish Menopause Society's 2026 position says these findings should not justify starting HRT only to boost weight loss.

The practical reading: take HRT if your symptoms call for it, and take a GLP-1 if your weight does. If you need both, the early evidence suggests they do not work against each other, and may help.

What each treatment does, and does not do

Goal	Menopausal hormone therapy	GLP-1 medication
Hot flashes and night sweats	The most effective treatment, and an FDA-approved use	Not a treatment for them; The Menopause Society says weight loss may help some women
Weight	Small effect on belly fat; not a weight-loss treatment	Antiobesity medications can produce weight loss of up to 20%, per The Menopause Society
Vaginal dryness and painful sex	Vaginal or systemic estrogen treats them	Not a treatment for them
Bone	FDA-approved to prevent postmenopausal osteoporosis	No bone indication
How long	Reassessed regularly with your provider	Long-term; stopping often brings weight back

In a Lilly analysis of the SURMOUNT-1 trial, tirzepatide worked about as well in postmenopausal women (23% weight loss vs 3% with placebo) as in women before menopause, so menopause itself does not blunt a GLP-1. For what to expect week by week, read how long a GLP-1 takes to work.

HRT and GLP-1 at Gala

Gala runs both programs, so you can be treated for menopause symptoms and for weight by the same service. Each is a separate plan with its own provider review:

Hormone therapy: FDA-approved estradiol and progesterone as a pill plan at $69 a month ($207 every 12 weeks), or a patch, gel or vaginal estradiol at $99 a month. Systemic HRT is for women 40 to 65.
Weight loss: compounded semaglutide from $69 a month or compounded tirzepatide from $99 a month. Compounded medications are not FDA-approved.

Start with either one. Women 40 to 65 who buy a GLP-1 plan are offered HRT right after checkout, and HRT patients are offered compounded tirzepatide unless an answer they already gave rules it out, such as pregnancy, blood pressure of 160/100 or higher, pancreatitis, insulin-treated diabetes, or a history of breast, endometrial, ovarian or colon cancer. A licensed provider still completes a full GLP-1 assessment before prescribing.

Tell both providers about every medicine you take, including birth control. Start your menopause assessment here, or see the compounded tirzepatide page first.

This article is for information only and is not medical advice. Talk to your healthcare provider before starting or combining treatments.

Frequently asked questions

Can you take HRT with a GLP-1?

Yes. The semaglutide and tirzepatide labels do not list menopausal hormone therapy as an interaction, and the two treat different problems. Your provider should know about every medicine you take, and tirzepatide users who rely on birth control pills need a backup method at the start and after dose increases.

Is Zepbound safe with HRT?

Zepbound's label does not mention menopausal hormone therapy. Its warning concerns oral birth control pills, whose absorption drops after starting or raising the dose, which can affect pregnancy prevention. Patches, gels and vaginal estradiol do not depend on stomach absorption.

Does HRT interfere with tirzepatide?

There is no evidence that HRT reduces tirzepatide's effect. In one Mayo Clinic study women on HRT lost more weight on tirzepatide (17% vs 14%), though a larger study found a difference only in the first 3 months.

Can I use an estradiol patch with Zepbound?

Nothing in Zepbound's label restricts it. An estradiol patch delivers hormone through the skin, so tirzepatide's slowing of stomach emptying does not affect how it is absorbed. Your provider still reviews both before prescribing.

Does HRT help GLP-1 weight loss?

Possibly, for semaglutide. Retrospective Mayo Clinic studies found women on hormone therapy lost slightly more weight on semaglutide, about 1 to 4 percentage points. Researchers say weight loss is not a reason to start HRT on its own.

What is the best medication for menopause weight gain?

GLP-1 medications such as semaglutide and tirzepatide produce the largest weight loss, up to about 20%, according to The Menopause Society. Hormone therapy treats hot flashes and other symptoms but has only a small effect on weight.

Ready to talk to a provider?

Your answers go to a licensed provider, who decides whether treatment is right for you. Learn more about Hormone Health.

Treatments: Estradiol pill or patch online · Progesterone for menopause · Vaginal estrogen online · Non-hormonal menopause treatment

Start your menopause assessment

More Hormone Health guides

Sources

This article is for general information and is not medical advice. Talk to a licensed provider about your own health.

HRT and GLP-1 Together: Treating Menopause Weight Gain From Both Sides